AAAS, FDLI Sponsor Landmark Meeting on Personalized Medicine Jun...(p Kennedy Institute of Ethics Per...),Health

> Kennedy Institute of Ethics

> Personalized Medicine Coalition

Morning panelists include:

> Finley Austin, Ph.D., Head, US External Research & Innovation Environment, Hoffmann-La Roche, Inc.

> Greg Downing, D.O., Ph.D., Program Director, Personalized Health Care, Immediate Office of the Secretary, Department of Health and Human Services

> Carolina Hinestrosa, M.A., M.P.H., Executive Vice President of Programs and Planning, National Breast Cancer Coalition

> Howard. P. Levy, M.D., Ph.D., Assistant Professor, Division of General Internal Medicine and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University

> Kavita Patel, M.D., M.S.H.S., Deputy Staff Director, Health Subcommittee of Senator Edward M. Kennedy

> Joan A. Scott, M.S., C.G.C., Deputy Director, Genetics and Public Policy Center, Johns Hopkins University

> Charles Rotimi, Ph.D., Director, NIH Intramural Center for Genomics and Health Disparities; Senior Investigator, Inherited Disease Research Branch, NHGRI

> Grail Sipes, J.D., Partner, Covington & Burling

Afternoon panelists include:

> Kevin T. Conroy, President and CEO, Third Wave Technologies, Inc.

> Steven I. Gutman, Ph.D., Director, Office of In Vitro Diagnostic Device Evaluation & Safety, CDRH, FDA

> Shiew-Mei Huang, Ph.D., Deputy Director for Science, Office of Clinical Pharmacology, CDER, FDA

> Steve McPhail, President and Chief Executive Officer, Expression Analysis, Inc.

> Bruce Quinn, M.D., Ph.D., Senior Health Policy Specialist, Foley Hoag LLP

> Allen D. Roses, M.D., Jefferson-Pilot Professor of Neurobiology and Genetics, Professor of Medicine, and Director, Deane Drug Discovery Institute, Duke University Medical Center; Senior Scholar, Fuqua School of Business; Member, Duke Institute of Genome Sciences and Policy

Jeffery N. Gibbs, Principal at Hyman, Phelps & McNamara, P.C. and Gail H. Javitt,
'/>"/>